26-10-2014

Prof. dr. Martine Antoine describes the use of the iVAC 3L as a mechanical left ventricular assist device for a patient suffering from cardiogenic shock.

A 65 year old female presented with cardiogenic shock, and rhythm problems. Despite 20 mcg/kg/min of dobutamine , the ejection fraction was 15%, the cardiac index was 1.4 L/min/m2 and mean arterial pressure was 65 mmHg. The lactate level was 14.8 mmol/L, pH value was 6.99, and creatinine value was 1.9 mg/dl.
The iVAC 3L was inserted via the right axillary artery, using a vascular graft. gaminátor játékok ingyen The position of the device was assured by X-ray. ACT was kept around 180 sec.

Insertion of the device was uneventful. After preparation of the entrance site, it took 7 min to insert the device. The patient’s pH value returned to normal after 10 hours.

At 5 days post-op, (drug treatment could be stopped) the cardiac index had increased to 3.5 L/min/m2, the ejection fraction was 20% off drugs and the mean arterial pressure had increased to 87 mmHg. bukmeker saytlari Biology was normalized, lactate level had decreased to 1 mmol/l, and creatinine level to 1. mg/dl. The patient was then weaned from the device. The patient left the hospital at day 32.

Testimonial

“The PulseCath iVAC 3L is an easy to use left ventricular assist device, able of effectively unloading the heart and increasing the patient’s cardiac output in cases of acute heart failure.”

– Dr. M. Antoine (Head of?) Department of Cardiac Surgery, Hôpital Erasme, Bruxelles, Belgium. gaminator játékok